Central Garden & Pet Q3 sales miss estimates on exit of pet distribution; lifts FY forecast
Central Garden & Pet Q3 sales miss estimates on exit of pet distribution; lifts FY forecast
Overview
U.S. pet and garden goods maker's preliminary fiscal Q3 net sales fell 8%, missing analyst expectations
GAAP diluted EPS for fiscal Q3 declined to $1.45 from $1.52 a year ago
Company raised fiscal 2026 non-GAAP EPS outlook and agreed to acquire 80% of TRIXIE
Outlook
Central Garden & Pet raises fiscal 2026 non-GAAP diluted EPS outlook to $2.85 or better
Company projects fiscal 2026 capital expenditures of about $50 mln
Outlook assumes competitive retail environment, value-oriented consumers, and inflation in select commodities
Result Drivers
BUSINESS EXIT IMPACT - Co said overall sales decline was primarily due to exit of pet distribution business, while organic sales grew 2%
MARGIN IMPROVEMENT - Co attributed margin expansion to exit of pet distribution business and disciplined execution
GARDEN SEGMENT GROWTH - Sales growth in Garden segment driven by Wild Bird, Fertilizer and Controls, and Grass Seeds
Company press release: ID:nBw46GWSFa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Sales | Miss | $882 mln | $895.76 mln (5 Analysts) |
Q3 EPS |
| $1.45 |
|
Q3 Net Income |
| $90 mln |
|
Q3 Operating Income | Miss | $126 mln | $134.80 mln (4 Analysts) |
Q3 Gross Profit |
| $317 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the food processing peer group is "buy"
Wall Street's median 12-month price target for Central Garden & Pet Co is $50.00, about 13.5% above its August 4 closing price of $44.07
The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 13 three months ago
Reuters Recommended Reads
Aug 5 - Freshpet Q2 revenue tops estimates; raises 2026 outlook
Aug 5 - Elanco Animal Health beats Q2 revenue estimates, raises FY guidance
Aug 3 - Clorox forecasts upbeat annual sales as demand improves
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Central Garden & Pet
See all newsBrief: Central Garden & Pet Acquires Burpee
Central Garden & Pet Co reports results for the quarter ended June 30 - Earnings Summary
Central Garden & Pet Q3 sales miss estimates on exit of pet distribution; lifts FY forecast
Brief: Central Garden & Pet Q3 EPS USD 1.45
Central Garden & Pet Co expected to post earnings of $1.53 a share - Earnings Preview